Chatbot could revolutionize migraine tracking for women
NCT ID NCT06920602
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tested whether an AI-powered voice chatbot is better than a traditional paper diary for tracking migraines in Hong Kong women. 49 women used both methods for one month each. The goal was to see which tool was more accurate, complete, and easy to use. The chatbot aims to make migraine tracking simpler and more reliable.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- AI-empowered voice-interactive chatbot
- What this could lead to
- If successful, this chatbot could offer a more accurate and user-friendly way for women to track migraines, potentially improving management.
- What could go wrong
- This is a small, completed trial with only 49 participants, so results may not apply broadly. The chatbot is a tracking tool, not a treatment, so it won't directly reduce migraines.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Hong Kong Polytechnic University
Hong Kong, HONG KONG, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a numbing nose treatment stop migraine pain in its tracks?
- Can migraine meds be safe while breastfeeding? a new study investigates
- Could a symptom registry unmask hidden migraine variants?
- A migraine-blocking antibody tested in children as young as 6
- Mind over migraine: brain network may explain why some expect side effects
- The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?